Prediagnosis soy food consumption and lung cancer survival in women.

PURPOSE We recently reported an inverse association between soy food intake and lung cancer risk among nonsmoking women. The effect size for aggressive lung cancers was larger than that observed for other types of lung cancer. Therefore, we hypothesized that soy consumption may favorably affect the overall survival of patients with lung cancer. PATIENTS AND METHODS This analysis included 444 women with incident lung cancer identified from the Shanghai Women's Health Study. Prediagnosis soy food intake was assessed at enrollment and reassessed 2 years later. Proportional hazards models were used to evaluate the association between soy food intake and overall survival. RESULTS Of the 444 patients with lung cancer, 318 died during follow-up. Initial analyses including all patients showed that higher intake of soy food was associated with better overall survival after adjusting for demographic and lifestyle characteristics and other nonclinical factors. Larger effect sizes for the association were found after additional adjustment for tumor stage and treatment in analyses including 301 patients with data available on these clinical factors. Compared with the median intake of soy food, fully adjusted hazard ratios for total mortality associated with the 10th, 30th, 70th, and 90th percentiles of intake were 1.81 (95% CI, 1.26 to 2.59), 1.25 (95% CI, 1.09 to 1.42), 0.88 (95% CI, 0.80 to 0.97), and 0.89 (95% CI, 0.68 to 1.16), respectively. Similar inverse associations were observed for dietary isoflavone intake. CONCLUSION This study suggests, to the best of our knowledge for the first time, that, among women with lung cancer, prediagnosis intake of soy food is associated with better overall survival.

[1]  X. Shu,et al.  Soy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis. , 2012, American journal of epidemiology.

[2]  G. Vlastos,et al.  Lung cancer mortality risk among breast cancer patients treated with anti‐estrogens , 2011, Cancer.

[3]  J. Manson,et al.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial , 2009, The Lancet.

[4]  R. Levy,et al.  The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. , 2009, Nutrition reviews.

[5]  Shadan Ali,et al.  Retracted: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines , 2009, Cancer.

[6]  X. Shu,et al.  Prospective cohort study of soy food intake and colorectal cancer risk in women. , 2009, The American journal of clinical nutrition.

[7]  M. Berhow,et al.  Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages. , 2008, Journal of agricultural and food chemistry.

[8]  K. Cao,et al.  Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  G. Scambia,et al.  Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice. , 2008, The Journal of nutrition.

[10]  J. Crowley,et al.  The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  Xu Zhang,et al.  Erratum to "A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model" [Computer Methods and Programs in Biomedicine 88 (2007) 95-101] , 2008, Comput. Methods Programs Biomed..

[12]  R. Mehta,et al.  Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. , 2007, Cancer research.

[13]  Xu Zhang,et al.  A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model , 2007, Comput. Methods Programs Biomed..

[14]  M. Heinonen,et al.  Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-κB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-κB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated , 2007, Mediators of inflammation.

[15]  J. Cline,et al.  Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. , 2006, Carcinogenesis.

[16]  X. Shu,et al.  Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study , 2006, BMJ : British Medical Journal.

[17]  M. Fishbein,et al.  Aromatase inhibitors in human lung cancer therapy. , 2005, Cancer research.

[18]  N. Rothman,et al.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.

[19]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[20]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[21]  R. Brant,et al.  Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. , 2001, JAMA.

[22]  K. Anderson,et al.  Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. , 2000, Cancer research.

[23]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[24]  W. Mazur,et al.  Phyto-oestrogens and Western diseases. , 1997, Annals of medicine.

[25]  C. Haslett,et al.  Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. , 1996, Cancer research.

[26]  Y. Lee,et al.  Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. , 1991, Journal of Korean medical science.

[27]  K E Stanley,et al.  Prognostic factors for survival in patients with inoperable lung cancer. , 1980, Journal of the National Cancer Institute.

[28]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[29]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[30]  A. Potti,et al.  Hormone replacement therapy is associated with decreased survival in women with lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Schiller,et al.  Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  X. Shu,et al.  Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study , 2004, European Journal of Clinical Nutrition.

[33]  J. Luketich,et al.  Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. , 2002, Cancer research.

[34]  M. Bennink.  Dietary soy reduces colon carcinogenesis in human and rats. Soy and colon cancer. , 2001, Advances in experimental medicine and biology.

[35]  Yiwei Li,et al.  p53-independent apoptosis induced by genistein in lung cancer cells. , 1999, Nutrition and cancer.

[36]  M. Nair,et al.  Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. , 1998, Nutrition and cancer.

[37]  Yiwei Li,et al.  Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. , 1998, Nutrition and cancer.

[38]  J. Gustafsson,et al.  Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. , 1997, Endocrinology.